Morin Beyeler

TL;DR: Patients with AIS and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non–CO VID-19 patients receiving treatment.

TL;DR: In this article, the authors describe frequency, clinical and radiological features, and 3-month outcomes of patients with ischemic stroke and COVID-19 in a nationwide stroke registry.

TL;DR: In this article , the authors evaluated the safety and outcomes of revascularization treatments in patients with acute ischemic stroke (AIS) and COVID-19 and found that patients with COVID19 had higher rates of intracranial bleeding complications and worse clinical outcomes than contemporaneous non-COVID19 patients receiving treatment.

TL;DR: The results suggest preservation in the stroke care of higher severity of disease through the first pandemic year and a global decline and shift to lower volume centers of stroke admission volumes, ICH volumes, and IVT volumes during the 1st year of the COVID-19 pandemic compared to the prior year.